Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

Charles K. Meshul, Regina K. Stallbaumer, Barry Taylor, Aaron Janowsky

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Sub-chronic treatment with the typical neuroleptic, haloperidol (0.5 mg/kg/d, s.c.), but not the atypical neuroleptic, clozapine (35 mg/kg/day, s.c.), causes an increase in synapses containing a perforated postsynaptic density (referred to as 'perforated' synapses) and in dopamine (DA) D2 receptors within the caudate nucleus [46]. To determine if there perforated synapses are glutamatergic, we systemically co-administered MK-801 (0.3 mg/kg/day for 2 weeks), a non-competitive antagonist at the N-methyl-d-aspartate (NMDA) receptor-associated ion channel, and haloperidol. MK-801 blocked the haloperidol-induced increase into the striatal also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold MK-801 into the striatum also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold electron microscopy using antibodies to glutamate indicated that the gold particles were localized within striatal presynaptic nerve terminals that make contact with perforated postsynaptic densities. These findings support the hypothesis that the haloperidol-induced increase in perforated synapses is regulated by the NMDA subtype of excitatory glutamate receptor. The increase in perforated synapses following administration of haloperidol, which is associated with a high incidence of extrapyramidal side effects (EPS), and the lack of a synaptic change following administration of clozapine, known to have a low frequency of EPS, suggests that glutanate synapses play a role in the motoric side effects that are observed with typical neuroleptic drug treatment.

Original languageEnglish (US)
Pages (from-to)181-195
Number of pages15
JournalBrain Research
Volume648
Issue number2
DOIs
StatePublished - Jun 20 1994

Fingerprint

Haloperidol
Synapses
Glutamic Acid
Dizocilpine Maleate
Gold
Antipsychotic Agents
Post-Synaptic Density
Corpus Striatum
Clozapine
Immunoelectron Microscopy
Dopamine D2 Receptors
Caudate Nucleus
Presynaptic Terminals
Glutamate Receptors
Ion Channels
Aspartic Acid
Antibodies
Incidence

Keywords

  • Electron microscopy
  • Extrapyramidal side effect
  • Glutamate antagonist
  • Glutamate immunocytochemistry
  • Perforated synapse

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. / Meshul, Charles K.; Stallbaumer, Regina K.; Taylor, Barry; Janowsky, Aaron.

In: Brain Research, Vol. 648, No. 2, 20.06.1994, p. 181-195.

Research output: Contribution to journalArticle

Meshul, Charles K. ; Stallbaumer, Regina K. ; Taylor, Barry ; Janowsky, Aaron. / Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. In: Brain Research. 1994 ; Vol. 648, No. 2. pp. 181-195.
@article{578e45e4598842d690e78fd774e7f672,
title = "Haloperidol-induced morphological changes in striatum are associated with glutamate synapses",
abstract = "Sub-chronic treatment with the typical neuroleptic, haloperidol (0.5 mg/kg/d, s.c.), but not the atypical neuroleptic, clozapine (35 mg/kg/day, s.c.), causes an increase in synapses containing a perforated postsynaptic density (referred to as 'perforated' synapses) and in dopamine (DA) D2 receptors within the caudate nucleus [46]. To determine if there perforated synapses are glutamatergic, we systemically co-administered MK-801 (0.3 mg/kg/day for 2 weeks), a non-competitive antagonist at the N-methyl-d-aspartate (NMDA) receptor-associated ion channel, and haloperidol. MK-801 blocked the haloperidol-induced increase into the striatal also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold MK-801 into the striatum also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold electron microscopy using antibodies to glutamate indicated that the gold particles were localized within striatal presynaptic nerve terminals that make contact with perforated postsynaptic densities. These findings support the hypothesis that the haloperidol-induced increase in perforated synapses is regulated by the NMDA subtype of excitatory glutamate receptor. The increase in perforated synapses following administration of haloperidol, which is associated with a high incidence of extrapyramidal side effects (EPS), and the lack of a synaptic change following administration of clozapine, known to have a low frequency of EPS, suggests that glutanate synapses play a role in the motoric side effects that are observed with typical neuroleptic drug treatment.",
keywords = "Electron microscopy, Extrapyramidal side effect, Glutamate antagonist, Glutamate immunocytochemistry, Perforated synapse",
author = "Meshul, {Charles K.} and Stallbaumer, {Regina K.} and Barry Taylor and Aaron Janowsky",
year = "1994",
month = "6",
day = "20",
doi = "10.1016/0006-8993(94)91117-7",
language = "English (US)",
volume = "648",
pages = "181--195",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

AU - Meshul, Charles K.

AU - Stallbaumer, Regina K.

AU - Taylor, Barry

AU - Janowsky, Aaron

PY - 1994/6/20

Y1 - 1994/6/20

N2 - Sub-chronic treatment with the typical neuroleptic, haloperidol (0.5 mg/kg/d, s.c.), but not the atypical neuroleptic, clozapine (35 mg/kg/day, s.c.), causes an increase in synapses containing a perforated postsynaptic density (referred to as 'perforated' synapses) and in dopamine (DA) D2 receptors within the caudate nucleus [46]. To determine if there perforated synapses are glutamatergic, we systemically co-administered MK-801 (0.3 mg/kg/day for 2 weeks), a non-competitive antagonist at the N-methyl-d-aspartate (NMDA) receptor-associated ion channel, and haloperidol. MK-801 blocked the haloperidol-induced increase into the striatal also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold MK-801 into the striatum also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold electron microscopy using antibodies to glutamate indicated that the gold particles were localized within striatal presynaptic nerve terminals that make contact with perforated postsynaptic densities. These findings support the hypothesis that the haloperidol-induced increase in perforated synapses is regulated by the NMDA subtype of excitatory glutamate receptor. The increase in perforated synapses following administration of haloperidol, which is associated with a high incidence of extrapyramidal side effects (EPS), and the lack of a synaptic change following administration of clozapine, known to have a low frequency of EPS, suggests that glutanate synapses play a role in the motoric side effects that are observed with typical neuroleptic drug treatment.

AB - Sub-chronic treatment with the typical neuroleptic, haloperidol (0.5 mg/kg/d, s.c.), but not the atypical neuroleptic, clozapine (35 mg/kg/day, s.c.), causes an increase in synapses containing a perforated postsynaptic density (referred to as 'perforated' synapses) and in dopamine (DA) D2 receptors within the caudate nucleus [46]. To determine if there perforated synapses are glutamatergic, we systemically co-administered MK-801 (0.3 mg/kg/day for 2 weeks), a non-competitive antagonist at the N-methyl-d-aspartate (NMDA) receptor-associated ion channel, and haloperidol. MK-801 blocked the haloperidol-induced increase into the striatal also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold MK-801 into the striatum also attenuated the haloperidol-induced increase in perforated synapses. Post-embedding immuno-gold electron microscopy using antibodies to glutamate indicated that the gold particles were localized within striatal presynaptic nerve terminals that make contact with perforated postsynaptic densities. These findings support the hypothesis that the haloperidol-induced increase in perforated synapses is regulated by the NMDA subtype of excitatory glutamate receptor. The increase in perforated synapses following administration of haloperidol, which is associated with a high incidence of extrapyramidal side effects (EPS), and the lack of a synaptic change following administration of clozapine, known to have a low frequency of EPS, suggests that glutanate synapses play a role in the motoric side effects that are observed with typical neuroleptic drug treatment.

KW - Electron microscopy

KW - Extrapyramidal side effect

KW - Glutamate antagonist

KW - Glutamate immunocytochemistry

KW - Perforated synapse

UR - http://www.scopus.com/inward/record.url?scp=0028305817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028305817&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)91117-7

DO - 10.1016/0006-8993(94)91117-7

M3 - Article

C2 - 7922533

AN - SCOPUS:0028305817

VL - 648

SP - 181

EP - 195

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -